home / stock / nrbo / nrbo news


NRBO News and Press, NeuroBo Pharmaceuticals Inc. From 09/12/22

Stock Information

Company Name: NeuroBo Pharmaceuticals Inc.
Stock Symbol: NRBO
Market: NASDAQ
Website: neurobopharma.com

Menu

NRBO NRBO Quote NRBO Short NRBO News NRBO Articles NRBO Message Board
Get NRBO Alerts

News, Short Squeeze, Breakout and More Instantly...

NRBO - NeuroBo Pharmaceuticals Announces Reverse Stock Split

NeuroBo Pharmaceuticals Announces Reverse Stock Split PR Newswire BOSTON , Sept. 12, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO) ("NeuroBo" or the "Company"), a clinical-stage biotechnology company, announced today a 1-for-30 reverse...

NRBO - NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations

NeuroBo Pharmaceuticals, Inc. Expands Management Team with the Appointment of Matthew Bardin, PharmD, BCPS as Senior Vice President Operations PR Newswire BOSTON , May 6, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-st...

NRBO - NeuroBo Pharmaceuticals GAAP EPS of -$0.66

NeuroBo Pharmaceuticals press release (NASDAQ:NRBO): FY GAAP EPS of -$0.66. Cash and Cash Equivalents were $16.4 million as of December 31, 2021, compared with $10.1 million as of December 31, 2020. For further details see: NeuroBo Pharmaceuticals GAAP EPS of -$0.66

NRBO - NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results

NeuroBo Pharmaceuticals Reports Full Year 2021 Financial Results PR Newswire BOSTON , April 1, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced financial results for the year en...

NRBO - NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D.

NeuroBo Pharmaceuticals, Inc. Expands Scientific Advisory Board with Appointment of Danamarie Belpulsi, M.D. PR Newswire BOSTON , March 15, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announ...

NRBO - BioCardia, Biophytis top healthcare gainers; Kiromic, Mainz Biomed among losers

Gainers: BioCardia BCDA +32%. Biophytis BPTS +17%. Mersana Therapeutics MRSN +7%. Liquidia (NASDAQ:LQDA) +5%. Vaccitech (NASDAQ:VACC) +3%. Losers: Kiromic BioPharma KRBP -17%. Mainz Biomed (NASDAQ:MYNZ) -9%. Vaccinex (NASDAQ:VCNX) -7%. NeuroBo Phar...

NRBO - NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors

NeuroBo Pharmaceuticals, Inc. Appoints D. Gordon Strickland to its Board of Directors PR Newswire BOSTON , Jan. 28, 2022 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company, today announced the appointment of D...

NRBO - Trading Penny Stocks? Top Stock Market News For January 24th, 2022

Buying Penny Stocks Today? Here’s What You Need to Know As we enter another week of trading penny stocks and blue chips, there is a lot to know. Right now, we’re witnessing the stock market post more potential signs of a negative trading day as well as a further crash with...

NRBO - Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Welcome back, trader! It’s time to get this week going with a breakdown of the biggest pre-market stock movers for Monday! Source: Shutterstock News moving stocks this morning include a buyout offer, a revers...

NRBO - 10 Low-Float Penny Stocks for Steel-Gutted Investors

InvestorPlace - Stock Market News, Stock Advice & Trading Tips One of the reasons why people have gravitated toward benchmark cryptocurrencies is that their supply tends to be deflationary. That is, despite ravenous demand for popular cryptos, their supply — controlled by a dece...

Previous 10 Next 10